Quantifying how location and dose of botulinum toxin injections affect muscle paralysis

Despite the widespread use of botulinum toxin to treat muscle dystonias, no method exists to quantify muscle paralysis in either human or nonhuman models. In this study we examined how the location, dose, and volume of botulinum injection affects paralysis in the rat tibialis anterior muscle. Paralysis was quantified by electrically stimulating the nerve to the tibialis anterior and then staining sections of the muscle for glycogen. The areas of glycogen‐containing fibers represented regions of botulinum action. The results showed that the most important injection technique is to inject botulinum directly into the motor endplate region of a muscle. Injections only 0.5 cm from the motor endplate resulted in a 50% decrease in paralysis. Increases in dose increased paralysis, however, some of that increase was simply due to the increased volume of injection. Thus, delivering toxin in small volumes near the MEP band of a muscle should produce the most effectiveparalysis. © 1993 John Wiley & Sons, Inc.

[1]  A. B. Scott,et al.  Botulinum A toxin injection as a treatment for blepharospasm. , 1985, Archives of ophthalmology.

[2]  J. Jankovic,et al.  Therapeutic uses of botulinum toxin. , 1991, The New England journal of medicine.

[3]  R. Sergott,et al.  Hemifacial spasm treated with botulinum A toxin injection. , 1985, Archives of ophthalmology.

[4]  S. Maurri,et al.  Responsiveness of idiopathic spasmodic torticollis to botulinum a toxin injection. a critical evaluation of five cases , 1990, Clinical Neurology and Neurosurgery.

[5]  E. Buckley,et al.  Botulinum toxin for blepharospasm: single-fiber EMG studies , 1986, Neurology.

[6]  M. Hallett,et al.  Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia , 1988, Neurology.

[7]  J. Jankovic Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy. , 1988, Advances in neurology.

[8]  M. Brin,et al.  Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia) , 1988, The Laryngoscope.

[9]  M. Brin,et al.  Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia , 1989, The Annals of otology, rhinology, and laryngology.

[10]  J. Carruthers,et al.  A Pilot Study on the Use of Botulinum Toxin in Spasmodic Torticollis , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[11]  A J Lees,et al.  Botulinum toxin treatment in spasmodic torticollis. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[12]  J Jankovic,et al.  Botulinum A toxin for cranial‐cervical dystonia , 1987, Neurology.

[13]  Davide Cozzolino,et al.  Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread , 1990, Head & neck.

[14]  T. Toyomasu,et al.  Genetic polymorphism of red cell glutamate-pyruvate transaminase in Japanese. , 1987, Human heredity.

[15]  L. Edström,et al.  Histochemical composition, distribution of fibres and fatiguability of single motor units. Anterior tibial muscle of the rat. , 1968, Journal of neurology, neurosurgery, and psychiatry.

[16]  C. L. Warner,et al.  Distant effects of local injection of botulinum toxin , 1987, Muscle & nerve.

[17]  M Hallett,et al.  Treatment of focal dystonias of the hand with botulinum toxin injections. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[18]  R. Burke,et al.  Tardive Akathisia: Motor Phenomena and Treatment , 1987 .

[19]  B. Wilffert,et al.  Ca2+ influx insensitive to organic Ca2+ entry blockers contributes to noradrenaline-induced contractions of the isolated guinea pig aorta. , 1990, Pharmacology.

[20]  N. Williams,et al.  TREATMENT OF ANISMUS IN INTRACTABLE CONSTIPATION WITH BOTULINUM A TOXIN , 1988, The Lancet.

[21]  H. Biller,et al.  Quantifying the spread of botulinum toxin through muscle fascia , 1991, The Laryngoscope.

[22]  J. Jankovic,et al.  Botulinum toxin injections for cervical dystonia , 1990, Neurology.

[23]  J. Jankovic,et al.  Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. , 1987, Archives of otolaryngology--head & neck surgery.

[24]  J. Jankovic,et al.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. , 1990, Journal of neurology, neurosurgery, and psychiatry.